NUCALA.COM: Keyword Density Checker

Total words: 4030 | 2-word phrases: 1103 | 3-word phrases: 1192 | 4-word phrases: 1218

PAGE INFO

Title	Try to keep the title under 60 characters (46 characters) Severe Asthma Treatment \| NUCALA (mepolizumab)
Description	Try to keep the meta description between 50 - 160 characters (158 characters) Learn more about NUCALA (mepolizumab), a maintenance treatment for patients with severe eosinophilic asthma. NUCALA is not used for sudden breathing problems.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

ONE WORD PHRASES 517 Words

#	Keyword	Frequency	Density
1	nucala	38	7.35%
2	to	30	5.80%
3	you	23	4.45%
4	your	20	3.87%
5	in	20	3.87%
6	is	17	3.29%
7	and	17	3.29%
8	a	15	2.90%
9	are	15	2.90%
10	for	15	2.90%

TWO WORD PHRASES 1103 Words

#	Keyword	Frequency	Density
1	you are	10	0.91%
2	not use	9	0.82%
3	or a	8	0.73%
4	nucala is	8	0.73%
5	if you	7	0.63%
6	is not	7	0.63%
7	breathing problems	7	0.63%
8	are a	6	0.54%
9	to treat	6	0.54%
10	severe asthma	6	0.54%
11	d i	6	0.54%
12	severe asthma?	6	0.54%
13	and older	5	0.45%
14	sit amet	5	0.45%
15	treat sudden	5	0.45%
16	sudden breathing	4	0.36%
17	not used	4	0.36%
18	eosinophilic asthma	4	0.36%
19	severe eosinophilic	4	0.36%
20	treatment for	4	0.36%

THREE WORD PHRASES 1192 Words

#	Keyword	Frequency	Density
1	to treat sudden	5	0.42%
2	treatment for patients	4	0.34%
3	used to treat	4	0.34%
4	not used to	4	0.34%
5	is not used	4	0.34%
6	nucala is not	4	0.34%
7	sudden breathing problems	4	0.34%
8	severe eosinophilic asthma	4	0.34%
9	any of the	4	0.34%
10	addon prescription maintenance	4	0.34%
11	for patients 6	4	0.34%
12	treat sudden breathing	3	0.25%
13	use nucala if	3	0.25%
14	if you are	3	0.25%
15	you are allergic	3	0.25%
16	are allergic to	3	0.25%
17	or any of	3	0.25%
18	allergic to mepolizumab	3	0.25%
19	to mepolizumab or	3	0.25%
20	mepolizumab or any	3	0.25%
21	do not use	3	0.25%
22	ingredients in nucala	3	0.25%
23	in nucala do	3	0.25%
24	not use nucala	3	0.25%
25	your healthcare provider	3	0.25%
26	and older with	3	0.25%
27	patients 6 and	3	0.25%
28	asthma nucala is	3	0.25%
29	nucala is an	3	0.25%
30	an addon prescription	3	0.25%

FOUR WORD PHRASES 1218 Words

#	Keyword	Frequency	Density
1	nucala is not used	4	0.33%
2	treatment for patients 6	4	0.33%
3	not used to treat	4	0.33%
4	is not used to	4	0.33%
5	or any of the	3	0.25%
6	maintenance treatment for patients	3	0.25%
7	for patients 6 and	3	0.25%
8	patients 6 and older	3	0.25%
9	to mepolizumab or any	3	0.25%
10	mepolizumab or any of	3	0.25%
11	severe eosinophilic asthma nucala	3	0.25%
12	with severe eosinophilic asthma	3	0.25%
13	an addon prescription maintenance	3	0.25%
14	eosinophilic asthma nucala is	3	0.25%
15	asthma nucala is not	3	0.25%
16	used to treat sudden	3	0.25%
17	to treat sudden breathing	3	0.25%
18	treat sudden breathing problems	3	0.25%
19	ingredients in nucala do	3	0.25%
20	prescription maintenance treatment for	3	0.25%
21	addon prescription maintenance treatment	3	0.25%
22	are allergic to mepolizumab	3	0.25%
23	allergic to mepolizumab or	3	0.25%
24	you are allergic to	3	0.25%
25	not use nucala if	3	0.25%
26	cras tempor laoreet euismod	2	0.16%
27	eu orci quis risus	2	0.16%
28	euismod donec a orci	2	0.16%
29	laoreet euismod donec a	2	0.16%
30	tempor laoreet euismod donec	2	0.16%
31	nunc eu orci quis	2	0.16%
32	orci luctus et ultrices	2	0.16%
33	faucibus orci luctus et	2	0.16%
34	in faucibus orci luctus	2	0.16%
35	primis in faucibus orci	2	0.16%
36	eleifend urna eget semper	2	0.16%
37	ipsum primis in faucibus	2	0.16%
38	in nucala do not	2	0.16%
39	tell your healthcare provider	2	0.16%
40	nucala tell your healthcare	2	0.16%

EXTERNAL LINKS

#	URL	Whois	Check
1	https://gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL-IFU-COMBINED.PDF	Whois	gsksource.com
2	https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL.PDF#nameddest=PIL	Whois	gsksource.com
3	https://gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL-IFU-COMBINED.PDF	Whois	gsksource.com
4	https://www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Nucala/pdf/NUCALA-PI-PIL.PDF#nameddest=PIL	Whois	gsksource.com
5	https://gskpro.com/en-us/products/nucala/for-severe-eosinophilic-asthma/	Whois	gskpro.com
6	https://www.facebook.com/NUCALA-mepolizumab-1981035652157938/	Whois	facebook.com
7	https://www.instagram.com/nucala_mepolizumab/?hl=en	Whois	instagram.com
8	https://privacy.gsk.com/en-us/pharmaceuticals/default/	Whois	gsk.com
9	https://www.gskforyou.com/medicare-part-d-patient-assistance/benlysta-and-nucala/	Whois	gskforyou.com
10	https://www.gskforyou.com/uninsured-patient-assistance/benlysta-and-nucala/	Whois	gskforyou.com
11	http://www.fda.gov/medwatch	Whois	fda.gov
12	https://contactus.gsk.com/callback.html	Whois	gsk.com
13	https://us.gsk.com/en-us/legal-notices/	Whois	gsk.com
14	https://privacy.gsk.com/en-us/pharmaceuticals/default/	Whois	gsk.com
15	https://us.gsk.com/en-us/about-our-ads/	Whois	gsk.com
16	https://www.gskforyou.com/	Whois	gskforyou.com
17	https://contactus.gsk.com/callback.html	Whois	gsk.com
18	https://www.contactus.gsk.com/optout/	Whois	gsk.com
19	https://www.facebook.com/NUCALA-mepolizumab-1981035652157938/	Whois	facebook.com
20	https://www.instagram.com/nucala_mepolizumab/?hl=en	Whois	instagram.com
21	https://us.gsk.com/	Whois	gsk.com

NUCALA.COM KEYWORD DENSITY CHECKER

PAGE INFO

ONE WORD PHRASES 517 Words

TWO WORD PHRASES 1103 Words

THREE WORD PHRASES 1192 Words

FOUR WORD PHRASES 1218 Words

EXTERNAL LINKS

Email Tools

Website Tools

NUCALA.COM KEYWORD DENSITY CHECKER

PAGE INFO

ONE WORD PHRASES 517 Words

TWO WORD PHRASES 1103 Words

THREE WORD PHRASES 1192 Words

FOUR WORD PHRASES 1218 Words

EXTERNAL LINKS

Email Tools

Website Tools

Modal Heading